July 25, 2024
Live Stream
Course# MEP25001
Department: Epidemiology and Biostatistics
Registration Fees
$400 Physicians
$350 Allied Health Professionals
$300 Residents/Fellows
Cancellation Policy
Cancellations received in writing before July 18, 2024 will be refunded, less an administrative fee of $75. No refunds will be made on cancellations received after that date.
Please submit your cancellation request at https://tiny.ucsf.edu/cmehelp
Overview
Now in its 21st year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.
TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.
Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.
Objectives
- Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
- Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
- Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
- Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
- Understand the evidence for vitamin D in the optimization of bone health;
- Recognize racial differences and disparities in osteoporosis care.
Accreditation
In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
UCSF has approved this program for CME credit: UCSF designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Geriatric: The approved credits shown above include 6.5 credits toward meeting the requirement under California Assembly Bill 1820, Geriatric Medicine.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 credit™ from organizations accredited by the ACCME.
Pharmacy: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 CreditsTM.
Course Outline
All program times listed are in Pacific Time Zone.
| Thursday, July 25, 2024 | |||
| SCREENING AND DIAGNOSIS | |||
| 8:00 AM | Zoom Registration and login, housekeeping, overview | ||
| 8:10 | G | Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis | Steven T. Harris, MD, FACP, FASBMR |
| 8:50 | Q&A | ||
| ANTIRESORPTIVE TREATMENT | |||
| 9:00 | G | Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk | Dennis M. Black, PhD |
| 9:30 | Q&A | ||
| 9:40 | G | Long-Term Treatment With and Following Denosumab | Karin Y. Wu, MD |
| 10:10 | Q&A | ||
| 10:20 | Break | ||
| ANABOLIC TREATMENT | |||
| 10:35 | G | Anabolic Agents: Mechanism, Efficacy, and Safety, and incorporation into Treatment Regimens | Anne L. Schafer, MD |
| 11:05 | Q&A | ||
| 11:15 | G | Racial Differences and Disparities in Osteoporosis Care | Nicole C. Wright, PhD, MPH |
| 11:45 | Q&A | ||
| 11:55 AM | Lunch Break | ||
| SPECIAL TOPICS IN OSTEOPOROSIS | |||
| 12:50 PM | G | Exercise for Fall and Fracture Prevention | Lora Giangregorio, PhD |
| 1:20 | Q&A | ||
| 1:30 | G | CKD and Skeletal Health | Deborah E. Sellmeyer, MD |
| 2:10 | Q&A | ||
| 2:20 | Rare Bone Disease | Yasaman Motlaghzadeh, MD | |
| 2:45 | Q&A | ||
| 2:55 | Break | ||
| 3:10 | G | DXA Interpretation and Pitfalls | Deborah Sellmeyer, MD |
| 3:40 | Q&A | ||
| 3:50 | G | Clinical Roundtable: Q&A with a Panel of Physicians | Dolores M. Shoback, MD Steven T. Harris, MD, FACP, FASBMR Deborah E. Sellmeyer, MD Anne L. Schafer, MD (facilitator) |
| 4:30 | Adjourn | ||
G: Geriatric Credit
Course Chairs
Anne L. Schafer, MD
Professor of Medicine
Chief of Endocrinology, San Francisco VA Health Care System
San Francisco, CA
Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics
University of California, San Francisco
Faculty
(University of California, San Francisco unless indicated)
Lora Giangregorio, PhD
Professor and Schlegel Research Chair in Mobility and Aging
Department of Kinesiology and Health Sciences
University of Waterloo and Schlegel-UW Research Institute for Aging
Steven T. Harris, MD, FACP, FASBMR
Clinical Professor of Medicine
Yasaman Motlaghzadeh, MD, MPH
Clinical Assistant Professor of Medicine
Division of Endocrinology, Gerontology and Metabolism
Stanford University, School of Medicine
Deborah E. Sellmeyer, MD
Clinical Professor of Medicine
Director, Metabolic Bone Diseases
Stanford University School of Medicine
Palo Alto, CA
Dolores M. Shoback, MD
Professor of Medicine
Karin C. Wu, MD
Assistant Professor of Medicine
University of California, San Francisco
San Francisco VA Health Care System
Nicole C. Wright, PhD, MPH
Associate Professor
Vice Chair of Academics
Director, MPH Program
Department of Epidemiology
School of Public Health
The University of Alabama at Birmingham
Birmingham, AL
Travel & Lodging
Live Stream Meeting
Previous Courses